Kenneth Nicholas Horne
Amministratore Delegato presso Symic Bio, Inc.
Profilo
Kenneth Nicholas Horne is currently the Chief Executive Officer & Director at Symic Bio, Inc., the Chief Executive Officer at Symic Holdings LLC, the Chief Executive Officer & Director at Capacity Bio, Inc., the Chief Executive Officer & Secretary at Typewriter Therapeutics, Inc., the Director at Bay Area Discovery Museum, the Vice President at Tautona Group, and the President of Digestome Therapeutics, Inc. He previously worked as the President, Chief Operating Officer & Director at Teon Therapeutics, Inc. Mr. Horne received his undergraduate and graduate degrees from Stanford University.
Posizioni attive di Kenneth Nicholas Horne
Società | Posizione | Inizio |
---|---|---|
Tautona Group
Tautona Group Investment ManagersFinance Tautona Group (Tautona Group) is a venture capital firm founded in 2010 by Duke Rohlen. The firm is headquartered in Menlo Park, California. | Investitore di Private Equity | 18/03/2011 |
Symic Bio, Inc.
Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Amministratore Delegato | - |
Bay Area Discovery Museum
Bay Area Discovery Museum Other Consumer ServicesConsumer Services Bay Area Discovery Museum operates as a preschool. The private company is based in Sausalito, CA and has subsidiaries in the United States. | Direttore/Membro del Consiglio | - |
Symic Holdings LLC
Symic Holdings LLC BiotechnologyHealth Technology Symic Holdings LLC develops new category of therapeutics. The company was founded by John Paderi, Kate Stuart and Alyssa Panitch and is headquartered in Emeryville, CA. | Amministratore Delegato | - |
Digestome Therapeutics, Inc.
Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Amministratore Delegato | - |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Amministratore Delegato | - |
Precedenti posizioni note di Kenneth Nicholas Horne
Società | Posizione | Fine |
---|---|---|
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Teon Therapeutics, Inc. operates as a pharmaceutical company. It focuses on cancer immunotherapy. The company was founded by Yao Lina, Fan Peidong, Elfaith Elzein, and Liiu Jiwen in March 2018 and is headquartered in Redwood City, CA. | Presidente | - |
Formazione di Kenneth Nicholas Horne
Stanford University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 7 |
---|---|
Symic Bio, Inc.
Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Health Technology |
Symic Holdings LLC
Symic Holdings LLC BiotechnologyHealth Technology Symic Holdings LLC develops new category of therapeutics. The company was founded by John Paderi, Kate Stuart and Alyssa Panitch and is headquartered in Emeryville, CA. | Health Technology |
Bay Area Discovery Museum
Bay Area Discovery Museum Other Consumer ServicesConsumer Services Bay Area Discovery Museum operates as a preschool. The private company is based in Sausalito, CA and has subsidiaries in the United States. | Consumer Services |
Tautona Group
Tautona Group Investment ManagersFinance Tautona Group (Tautona Group) is a venture capital firm founded in 2010 by Duke Rohlen. The firm is headquartered in Menlo Park, California. | Finance |
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Teon Therapeutics, Inc. operates as a pharmaceutical company. It focuses on cancer immunotherapy. The company was founded by Yao Lina, Fan Peidong, Elfaith Elzein, and Liiu Jiwen in March 2018 and is headquartered in Redwood City, CA. | Commercial Services |
Digestome Therapeutics, Inc.
Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Health Services |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Health Technology |
- Borsa valori
- Insiders
- Kenneth Nicholas Horne